Ashoka WhiteOak bought 561,000 shares of Thyrocare Technologies for ₹35.01 Cr at ₹624.00 apiece in a block deal.
A healthcare diagnostics provider, Thyrocare Technologies operates a network of diagnostic centers across India delivering laboratory testing and pathology services. The company partners with hospitals, clinics, and independent laboratories to offer affordable diagnostic solutions to patients nationwide. Its distinctive approach combines technology-enabled operations with cost-effective service delivery, making quality diagnostic care accessible across urban and semi-urban markets in India.
India equity vehicle of WhiteOak Capital, the Singapore-headquartered manager founded in 2017 by Prashant Khemka, former CIO of Goldman Sachs Asset Management's India Equity and Global Emerging Markets businesses. WhiteOak group manages USD 10.8 bn (~Rs 96,000 cr) across SMAs and funds. Ashoka India Opportunities Fund ranks as the best-performing India UCITS fund since 2018 inception.